South Korea, India, the United States, Japan, and the European Union (EU) have come together to launch Biopharmaceutical Alliance to put joint efforts into building a resilient supply chain in the biopharmaceutical sector.
Key points
- The inaugural meeting of the Biopharmaceutical Alliance was held in San Diego during the Bio International Convention 2024.
- The alliance was launched in response to the drug supply shortages experienced during the Covid-19 pandemic.
- The members acknowledged that the production of essential raw materials and ingredients is concentrated in a few countries and agreed to work together to build a detailed pharmaceutical supply chain map.
